Read the Latest ISN Journal Editorial Selections
Kidney International®
The study assesses the effects of newer kidney protective agents on endpoints, including smaller proportional declines in eGFR, to compare relative event rates and the magnitude of observed treatment effects.
They found that in populations at high risk of CKD progression, the relative effects of newer kidney protective therapies are similar across endpoints based on varying eGFR decline thresholds.
Kidney International Reports®
Population Frequency of Undiagnosed Fabry Disease in the General Population
According to researchers in Australia, Fabry disease is more common than previously recognized and still underdiagnosed, especially in women.
